These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 33835853)

  • 1. Reasons for Choice of Antiretroviral Regimens in HIV Patients Presenting Late for Initial Treatment in Europe.
    Schuettfort G; Cabello A; Cotter AG; Leuw PDE; Górgolas M; Hamzah L; Herrmann E; Kann G; Khaykin P; Mena A; Stephan C; Haberl AE
    AIDS Patient Care STDS; 2021 Apr; 35(4):110-115. PubMed ID: 33835853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France.
    Pugliese P; Joly V; Valantin MA; Cotte L; Huleux T; Allavena C; Reynes J; Poizot-Martin I; Bani-Sadr F; Cuzin L;
    Med Mal Infect; 2019 Jun; 49(4):264-269. PubMed ID: 30409541
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems.
    Papadopoulos A; Thomas K; Protopapas K; Antonyak S; Begovac J; Dragovic G; Gökengin D; Aimla K; Krasniqi V; Lakatos B; Mardarescu M; Matulionyte R; Mulabdic V; Oprea C; Panteleev A; Sedláček D; Sojak L; Skrzat-Klapaczyńska A; Vassilenko A; Yancheva N; Yurin O; Horban A; Kowalska JD;
    HIV Med; 2023 Apr; 24(4):462-470. PubMed ID: 36196025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy in treatment-naïve patients with HIV infection.
    Camacho R; Teófilo E
    Curr Opin HIV AIDS; 2011 Dec; 6 Suppl 1():S3-11. PubMed ID: 22156777
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reasons for noncompliance with the national guidelines for initial antiretroviral therapy of HIV-infected patients in Spain, 2010-2015.
    Suárez-García I; González J; Berenguer J; García F; Portilla J; Muga R; Moreno S; Jarrín I;
    Enferm Infecc Microbiol Clin (Engl Ed); 2019 Nov; 37(9):580-587. PubMed ID: 30982676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sociodemographic and clinical factors associated with the preference between NNRTIs and PIs for the initial treatment of HIV infection: Perfil-es study.
    Viciana P; Ocampo A; Hevia H; Palazuelos M; Ledesma F
    AIDS Care; 2016 Oct; 28(10):1321-6. PubMed ID: 27140483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Executive summary of the GESIDA/National AIDS Plan Consensus Document on antiretroviral therapy in adults infected by the human immunodeficiency virus (updated January 2015).
    ; Berenguer J; Polo R; Aldeguer JL; Lozano F; Aguirrebengoa K; Arribas JR; Blanco JR; Boix V; Casado JL; Clotet B; Crespo M; Domingo P; Estrada V; García F; Gatell JM; González-García J; Gutiérrez F; Iribarren JA; Knobel H; Llibre JM; Locutura J; López JC; Miró JM; Moreno S; Podzamczer D; Portilla J; Pulido F; Ribera E; Riera M; Rubio R; Santos J; Sanz-Moreno J; Sanz J; Téllez MJ; Tuset M; Rivero A
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):544-56. PubMed ID: 26021186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends and factors associated with modification or discontinuation of the initial antiretroviral regimen during the first year of treatment in the Turkish HIV-TR Cohort, 2011-2017.
    Korten V; Gökengin D; Eren G; Yıldırmak T; Gencer S; Eraksoy H; Inan D; Kaptan F; Dokuzoğuz B; Karaoğlan I; Willke A; Gönen M; Ergönül Ö;
    AIDS Res Ther; 2021 Jan; 18(1):4. PubMed ID: 33422112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy.
    Humphreys EH; Chang LW; Harris J
    Cochrane Database Syst Rev; 2010 Jun; (6):CD006517. PubMed ID: 20556768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiretroviral treatment outcomes among late HIV presenters initiating treatment with integrase inhibitors or protease inhibitors.
    Schuettfort G; Boekenkamp L; Cabello A; Cotter AG; De Leuw P; Doctor J; Górgolas M; Hamzah L; Herrmann E; Kann G; Khaykin P; Mallon PW; Mena A; Del Palacio Tamarit M; Sabin CA; Stephan C; Wolf T; Haberl AE
    HIV Med; 2021 Jan; 22(1):47-53. PubMed ID: 33047484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
    Gupta SB; Pujari SN; Joshi SR; Patel AK;
    J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment of antiretroviral third agent virologic durability after initiation of first antiretroviral regimen.
    Varriano B; Sandler I; Loutfy M; Steinberg S; Smith G; Kovacs C; Brunetta J; Fletcher D; Knox D; Merkley B; Chang B; Tilley D; Acsai M; Crouzat F
    Int J STD AIDS; 2019 Jun; 30(7):680-688. PubMed ID: 31042101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].
    Panel de expertos de GESIDA y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2011 Mar; 29(3):209.e1-103. PubMed ID: 21388714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
    Chang LW; Harris J; Humphreys E
    Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time spent with residual viraemia after virological suppression below 50 HIV-RNA copies/mL according to type of first-line antiretroviral regimen.
    Gianotti N; Galli L; Galizzi N; Ripa M; Andolina A; Nozza S; Spagnuolo V; Poli A; Lazzarin A; Castagna A
    Int J Antimicrob Agents; 2018 Oct; 52(4):492-499. PubMed ID: 30009958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interpreting the reasons for the choice and changing of two drug regimens in an observational cohort: comparison of a ritonavir-boosted protease inhibitor-based versus a nonnucleoside reverse transcriptase inhibitor-based first-line regimen.
    Jarrin I; Hernández-Novoa B; Alejos B; Santos I; Lopez-Aldeguer J; Riera M; Gutiérrez F; Rubio R; Antela A; Blanco JR; Moreno S;
    HIV Med; 2014 Oct; 15(9):547-56. PubMed ID: 24655804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of Integrase Strand Transfer Inhibitor Associated Resistance in Antiretroviral Therapy Naïve and Experienced Individuals from Western India.
    Karade S; Sen S; Sashindran VK
    AIDS Res Hum Retroviruses; 2019 Jun; 35(6):567-571. PubMed ID: 30793915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.